Legal Opinion
Doran v. Glaxosmithkline PLC
District Court, D. Connecticut
Decided June 10, 2022No. 3:21-cv-01228Unknown
1Opinion
UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT ALAN DORAN, Administrator for the estate of Rachel Hope Doran, Plaintiff, No. 3:21-cv-1228 (JAM) v. GLAXOSMITHKLINE PLC et al., Defendants. ORDER DENYING MOTION TO DISMISS Rachel Hope Doran died after her doctor prescribed a brand-name drug known as Lamictal and after her pharmacy filled the prescription with a bio-equivalent generic drug known as lamotrigine. The brand-name drug that her doctor prescribed was manufactured and marketed by the defendants in this action—Glaxosmithkline PLC and Glaxosmithkline LLC (collectively, “GSK”). The…
2Cases cited25 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Wyeth v. LevineSupreme Court of the United States · 2009
- Kim v. KimmCourt of Appeals for the Second Circuit · 2018
- PLIVA, Inc. v. MensingSupreme Court of the United States · 2011
- Gibbons v. Bristol-Myers Squibb Co.Court of Appeals for the Second Circuit · 2019
20 more not listed; retrieve them via the Exa API.